Article · Revue · 2026

Synergistic in vitro anticancer activity of doxorubicin-betulinic acid against neuroblastoma (SH-SY5Y) and lung carcinoma (A549) supported by in silico targeting of ALK

Onoja O. Joel, Pirun Mikled, Jude Y. Betow, Warinthorn Chavasiri

Scientific African

• Accès ouvert · Doré
• International · 3 pays

Le lire10.1016/j.sciaf.2026.e03285